P80 DIVERGENT GUIDELINES REGARDING METHOTREXATE PRESCRIBING IN THE UK: TIME FOR HEPATOLOGISTSTO PROVIDE DIRECTION?

L Turner; M Veysey; J Hutchinson; C Millson

doi:10.1136/gutjnl-2020-BASL.90

P80 DIVERGENT GUIDELINES REGARDING METHOTREXATE PRESCRIBING IN THE UK: TIME FOR HEPATOLOGISTSTO PROVIDE DIRECTION?

L Turner, M Veysey, J Hutchinson, C Millson

School of Medicine and Psychology

Research output: Contribution to conference › Abstract › peer-review

Abstract

Introduction Low dose methotrexate (MTX), an effective treatment for immune-mediated diseases, has been used by multiple specialities since the 1960s. Historically, MTX-induced hepatotoxicity dictated its potential use; only being advocated in patients with ‘life-ruining’ disease and regular liver biopsies were mandatory.1 Guidelines have been divergent across various specialities and this persists today.

Original language	English
Pages	A45-A46
Number of pages	2
DOIs	https://doi.org/10.1136/gutjnl-2020-BASL.90
Publication status	Published - 1 Sept 2020

Access to Document

10.1136/gutjnl-2020-BASL.90

https://www.webofscience.com/api/gateway?GWVersion=2SrcApp=PARTNER_APPSrcAuth=LinksAMRKeyUT=WOS:000616580200091DestLinkType=FullRecordDestApp=ALL_WOSUsrCustomerID=3567906c6fc598e4a73915c2777eae93

Cite this

@conference{eeabe7ab624346d0a9bca1290b31ded2,

title = "P80 DIVERGENT GUIDELINES REGARDING METHOTREXATE PRESCRIBING IN THE UK: TIME FOR HEPATOLOGISTSTO PROVIDE DIRECTION?",

abstract = "Introduction Low dose methotrexate (MTX), an effective treatment for immune-mediated diseases, has been used by multiple specialities since the 1960s. Historically, MTX-induced hepatotoxicity dictated its potential use; only being advocated in patients with {\textquoteleft}life-ruining{\textquoteright} disease and regular liver biopsies were mandatory.1 Guidelines have been divergent across various specialities and this persists today. ",

author = "L Turner and M Veysey and J Hutchinson and C Millson",

year = "2020",

month = sep,

day = "1",

doi = "10.1136/gutjnl-2020-BASL.90",

language = "English",

pages = "A45--A46",

}

TY - CONF

T1 - P80 DIVERGENT GUIDELINES REGARDING METHOTREXATE PRESCRIBING IN THE UK

T2 - TIME FOR HEPATOLOGISTSTO PROVIDE DIRECTION?

AU - Turner, L

AU - Veysey, M

AU - Hutchinson, J

AU - Millson, C

PY - 2020/9/1

Y1 - 2020/9/1

N2 - Introduction Low dose methotrexate (MTX), an effective treatment for immune-mediated diseases, has been used by multiple specialities since the 1960s. Historically, MTX-induced hepatotoxicity dictated its potential use; only being advocated in patients with ‘life-ruining’ disease and regular liver biopsies were mandatory.1 Guidelines have been divergent across various specialities and this persists today.

AB - Introduction Low dose methotrexate (MTX), an effective treatment for immune-mediated diseases, has been used by multiple specialities since the 1960s. Historically, MTX-induced hepatotoxicity dictated its potential use; only being advocated in patients with ‘life-ruining’ disease and regular liver biopsies were mandatory.1 Guidelines have been divergent across various specialities and this persists today.

U2 - 10.1136/gutjnl-2020-BASL.90

DO - 10.1136/gutjnl-2020-BASL.90

M3 - Abstract

SP - A45-A46

ER -

P80 DIVERGENT GUIDELINES REGARDING METHOTREXATE PRESCRIBING IN THE UK: TIME FOR HEPATOLOGISTSTO PROVIDE DIRECTION?

Abstract

Access to Document

Fingerprint

Cite this